• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    8/10/23 1:17:29 PM ET
    $AKA
    $AKU
    $ALRM
    $AMRS
    Catalog/Specialty Distribution
    Consumer Discretionary
    Medical Specialities
    Health Care
    Get the next $AKA alert in real time by email

    Gainers

    • Edible Garden AG Incorporated (NASDAQ:EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
    • Capri Holdings Limited (NYSE:CPRI) climbed 56.1% to $54.03 after Tapestry announced a definitive agreement to acquire the company.
    • Blend Labs, Inc. (NYSE:BLND) rose 32% to $1.6198 following better-than-expected second-quarter results.
    • Athersys, Inc. (NASDAQ:ATHX) gained 31% to $0.5783.
    • Yellow Corporation (NASDAQ:YELL) climbed 30% to $2.21.
    • Holley Inc. (NYSE:HLLY) surged 26% to $7.83 after the company posted upbeat second-quarter results and raised FY23 revenue outlook.
    • WeWork Inc. (NYSE:WE) shares gained 21% to $0.1560. WeWork shares fell over 38% on Wednesday after the company reported worse-than-expected second-quarter financial results.
    • LifeMD, Inc. (NASDAQ:LFMD) climbed 20% to $4.39 following strong quarterly results.
    • YETI Holdings, Inc. (NYSE:YETI) climbed 19% to $47.08 after the company reported better-than-expected second-quarter adjusted EPS results and raised FY23 adjusted EPS and sales growth guidance.
    • AppLovin Corporation (NASDAQ:APP) shares gained 19% to $34.97 after the company reported better-than-expected second-quarter results.
    • Alarm.com Holdings, Inc. (NASDAQ:ALRM) climbed 18.8% to $58.48 after the company reported better-than-expected second-quarter financial results and issued guidance.
    • CleanSpark, Inc. (NASDAQ:CLSK) rose 17.5% to $5.94 following a narrower-than-expected quarterly loss.
    • CS Disco, Inc. (NYSE:LAW) gained 16.3% to $9.93 following strong quarterly results.
    • Carrols Restaurant Group, Inc. (NASDAQ:TAST) gained 16% to $7.18 following strong quarterly results.
    • Seneca Foods Corporation (NASDAQ:SENEA) jumped 15.4% to $47.45 following quarterly results.
    • PHAXIAM Therapeutics S.A. (NASDAQ:PHXM) shares climbed 15.1% to $0.5020 after gaining 6% on Wednesday.
    • Entravision Communications Corporation (NYSE:EVC) rose 14.7% to $4.2550.
    • MacroGenics, Inc. (NASDAQ:MGNX) surged 14.4% to $5.70 after posting a profit for the second quarter.
    • GoodRx Holdings, Inc. (NASDAQ:GDRX) rose 14.4% to $9.09.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) gained 14% to $4.85.
    • Missfresh Limited (NASDAQ:MF) climbed 12.9% to $1.75.
    • LiveRamp Holdings, Inc. (NASDAQ:RAMP) gained 12.8% to $30.56 following upbeat quarterly results.
    • United Insurance Holdings Corp. (NASDAQ:UIHC) climbed 10.7% to $7.99.
    • Novavax, Inc. (NASDAQ:NVAX) rose 10.1% to $7.84.
    • Harmonic Inc. (NASDAQ:HLIT) climbed 8.6% to $10.99. Raymond James upgraded Harmonic from Outperform to Strong Buy and raised the price target from $15 to $16.
    • MDxHealth SA (NASDAQ:MDXH) shares gained 8.5% to $3.7863 after the company said Cigna has expanded commercial and Medicare Advantage coverage to include the Company’s Select mdx for Prostate Cancer test.
    • Vistagen Therapeutics, Inc. (NASDAQ:VTGN) rose 5.1% to $7.39. AffaMed said that its partner Vistagen Therapeutics reported positive top-line results from its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol nasal spray in adults diagnosed with social anxiety disorder.

    Losers

    • Galera Therapeutics, Inc. (NASDAQ:GRTX) shares fell 84.7% to $0.3426 after the company announced it received a Complete Response Letter from the FDA for avasopasem manganese.
    • Amyris, Inc. (NASDAQ:AMRS) fell 78.1% to $0.0751 after the company announced it filed for Chapter 11 bankruptcy.
    • Origin Materials, Inc. (NASDAQ:ORGN) fell 65.2% to $1.5050 after the company reported mixed second-quarter financial results.
    • SciSparc Ltd. (NASDAQ:SPRC) shares declined 60.9% to $0.1935 after the company reported a proposed underwritten public offering of approximately $1.3 million.
    • Matinas BioPharma Holdings, Inc. (NYSE:MTNB) fell 46% to $0.1784 after the company reported second-quarter results.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) declined 36.2% to $0.2498. TD Cowen downgraded Sunlight Finl from Outperform to Market Perform.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) fell 31.6% to $0.4379 after the company reported worse-than-expected second-quarter financial results and issued FY23 net sales guidance below estimates.
    • Magnite, Inc. (NASDAQ:MGNI) fell 29.9% to $8.65 after the company reported second-quarter financial results.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) dipped 28% to $1.18 following a wider-than-expected quarterly loss.
    • Virios Therapeutics, Inc. (NASDAQ:VIRI) fell 26.7% to $1.1496 following a wider-than-expected quarterly loss.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) fell 22.6% to $2.6250 after the company reported second-quarter financial results and withdrew its FY23 guidance.
    • Ebix, Inc. (NASDAQ:EBIX) dipped 22.5% to $16.83 after the company reported worse-than-expected quarterly financial results.
    • Innoviz Technologies Ltd. (NASDAQ:INVZ) shares fell 21.5% to $2.4650 as the company priced $65 million upsized public offering of 26 million ordinary shares at $2.50 per share.
    • Delcath Systems, Inc. (NASDAQ:DCTH) dipped 20.8% to $3.0650 following weak sales.
    • Surrozen, Inc. (NASDAQ:SRZN) tumbled 20.7% to $0.7047 after posting a wider quarterly loss.
    • FutureFuel Corp. (NYSE:FF) fell 20.7% to $7.83 after posting a wider quarterly loss.
    • Akumin Inc. (NASDAQ:AKU) declined 20.7% to $0.1622 after posting a wider loss for the latest quarter.
    • STRATA Skin Sciences, Inc. (NASDAQ:SSKN) declined 20.7% to $0.6899 following weak quarterly results.
    • Wolverine World Wide, Inc. (NYSE:WWW) fell 20.2% to $9.41 after the company reported second-quarter results and lowered its full-year outlook. The company also terminated the employment of Brendan Hoffman as CEO
    • Movella Holdings Inc. (NASDAQ:MVLA) declined 19.8% to $1.4275 following weak quarterly sales.
    • SunOpta Inc. (NASDAQ:STKL) fell 19.2% to $4.75 after the company reported a year-over-year decrease in second-quarter adjusted EPS results and worse-than-expected sales results. The company also cut FY23 revenue outlook below estimates.
    • OneSpan Inc. (NASDAQ:OSPN) fell 17.6% to $10.99 following weak results.
    • Enerflex Ltd. (NYSE:EFXT) declined 17.4% to $6.59 following second-quarter results.
    • Pangaea Logistics Solutions, Ltd. (NASDAQ:PANL) fell 16.1% to $5.84 after the company reported weak second-quarter financial results.
    • Computer Programs and Systems, Inc. (NASDAQ:CPSI) dipped 16% to $21.98 following weak results.
    • TaskUs, Inc. (NASDAQ:TASK) shares fell 13.4% to $10.36 after the company issued weak sales outlook.
    • Tapestry, Inc. (NYSE:TPR) declined 13% to $35.87 after the company announced a definitive agreement to acquire Capri Holdings.
    • Plug Power Inc. (NASDAQ:PLUG) tumbled 12.1% to $9.46 after the company reported mixed second-quarter financial results.
    • EnerSys (NYSE:ENS) fell 10.4% to $92.07 following weak quarterly sales.
    • Krispy Kreme, Inc. (NASDAQ:DNUT) fell 10.4% to $12.90 following weak quarterly sales.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shares fell 10.2% to $1.8099 following second-quarter financial results.
    • 180 Life Sciences Corp. (NASDAQ:ATNF) fell 9.2% to $0.7661 after gaining around 12% on Wednesday.
    • CarGurus, Inc. (NASDAQ:CARG) declined 6% to $18.09 following quarterly results.
    • Blackstone Secured Lending Fund (NYSE:BXSL) shares declined 5.5% to $27.17 after the company priced public offering of common shares.

     

    Now Read This: Top 5 Materials Stocks You May Want To Dump This Month

    Get the next $AKA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKA
    $AKU
    $ALRM
    $AMRS

    CompanyDatePrice TargetRatingAnalyst
    Surrozen Inc.
    $SRZN
    4/21/2026Buy
    TD Cowen
    Innoviz Technologies Ltd.
    $INVZ
    4/14/2026$0.75Buy → Neutral
    Goldman
    Applovin Corporation
    $APP
    4/14/2026$520.00Buy
    Argus
    MacroGenics Inc.
    $MGNX
    4/10/2026$9.00Neutral → Buy
    B. Riley Securities
    Applovin Corporation
    $APP
    4/9/2026$710.00Outperform
    Macquarie
    Blackstone Secured Lending Fund
    $BXSL
    4/9/2026$24.50Buy → Neutral
    B. Riley Securities
    Krispy Kreme Inc.
    $DNUT
    3/26/2026$6.00Equal Weight → Overweight
    CapitalOne
    Wolverine World Wide Inc.
    $WWW
    3/26/2026$21.00Buy
    Needham
    More analyst ratings

    $AKA
    $AKU
    $ALRM
    $AMRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Tcg Crossover Gp Ii, Llc bought $1,220,362 worth of shares (48,997 units at $24.91) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    3/16/26 7:05:51 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Enns Lucie bought $24,537 worth of Common Shares of Beneficial Interest (1,045 units at $23.48) (SEC Form 4)

    4 - Blackstone Secured Lending Fund (0001736035) (Issuer)

    3/16/26 4:30:29 PM ET
    $BXSL
    Trusts Except Educational Religious and Charitable
    Finance

    Trustee Clark James Frederic bought $17,835 worth of Common Shares of Beneficial Interest (750 units at $23.78), increasing direct ownership by 38% to 2,750 units (SEC Form 4)

    4 - Blackstone Secured Lending Fund (0001736035) (Issuer)

    3/12/26 4:30:02 PM ET
    $BXSL
    Trusts Except Educational Religious and Charitable
    Finance

    $AKA
    $AKU
    $ALRM
    $AMRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wickramasinghe Mahes

    4 - SunOpta Inc. (0000351834) (Issuer)

    4/20/26 9:50:29 PM ET
    $STKL
    Farming/Seeds/Milling
    Industrials

    SEC Form 4 filed by Keating Leslie Starr

    4 - SunOpta Inc. (0000351834) (Issuer)

    4/20/26 9:47:19 PM ET
    $STKL
    Farming/Seeds/Milling
    Industrials

    SEC Form 4 filed by Reynoso Diego

    4 - SunOpta Inc. (0000351834) (Issuer)

    4/20/26 9:45:36 PM ET
    $STKL
    Farming/Seeds/Milling
    Industrials

    $AKA
    $AKU
    $ALRM
    $AMRS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-7) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 10/01/2024. Application Category: NDA, Application Number: 201848, Application Classification: REMS

    10/2/24 4:43:10 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AKA
    $AKU
    $ALRM
    $AMRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Entravision to Announce First Quarter 2026 Financial Results

    Entravision (NYSE:EVC), a media and advertising technology company, announced today that it will release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. The company will host a webinar to discuss its results followed by a question-and-answer session at 1:30 p.m. PT/ 4:30 p.m. ET the same day. The webinar may be accessed on the company's Investor Relations website at investor.entravision.com or via webinar registration. The webinar will also be archived on the company's Investor Relations website under the Events section. About Entravision Entravision (NYSE:EVC) is a media and advertising technology company. In the U.S., we maintain a diversified

    4/23/26 4:05:00 PM ET
    $EVC
    Broadcasting
    Industrials

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Delcath Systems to Host First Quarter 2026 Earnings Call

    Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 7, 2026, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2026. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call. Event Date: Thursday, May 7, 2026 Time: 8:30 AM Eastern Time Participant Numbers: Toll Free: 1-800-717-1738 International: 1-646-307-1865 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1757946&tp_key=463dd4d428 A replay of the webinar will be available short

    4/23/26 8:30:00 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    $AKA
    $AKU
    $ALRM
    $AMRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Surrozen

    TD Cowen initiated coverage of Surrozen with a rating of Buy

    4/21/26 7:35:41 AM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Innoviz Technologies downgraded by Goldman with a new price target

    Goldman downgraded Innoviz Technologies from Buy to Neutral and set a new price target of $0.75

    4/14/26 8:15:50 AM ET
    $INVZ
    Auto Parts:O.E.M.
    Consumer Discretionary

    Argus initiated coverage on AppLovin with a new price target

    Argus initiated coverage of AppLovin with a rating of Buy and set a new price target of $520.00

    4/14/26 8:04:53 AM ET
    $APP
    Computer Software: Programming Data Processing
    Technology

    $AKA
    $AKU
    $ALRM
    $AMRS
    SEC Filings

    View All

    SEC Form DEFA14A filed by Alarm.com Holdings Inc.

    DEFA14A - Alarm.com Holdings, Inc. (0001459200) (Filer)

    4/23/26 5:17:59 PM ET
    $ALRM
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Alarm.com Holdings Inc.

    DEF 14A - Alarm.com Holdings, Inc. (0001459200) (Filer)

    4/23/26 5:15:20 PM ET
    $ALRM
    Computer Software: Prepackaged Software
    Technology

    SEC Form SCHEDULE 13G filed by Surrozen Inc.

    SCHEDULE 13G - Surrozen, Inc./DE (0001824893) (Subject)

    4/23/26 4:59:35 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKA
    $AKU
    $ALRM
    $AMRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Organogenesis Holdings Inc.

    SC 13D - Organogenesis Holdings Inc. (0001661181) (Subject)

    11/19/24 4:05:57 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Delcath Systems Inc.

    SC 13D/A - DELCATH SYSTEMS, INC. (0000872912) (Subject)

    11/15/24 10:33:51 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    $AKA
    $AKU
    $ALRM
    $AMRS
    Leadership Updates

    Live Leadership Updates

    View All

    DISCO Appoints Toby Williams to Board of Directors

    Public-company software executive brings growth focus and broad C-Suite expertise DISCO (NYSE:LAW), a creator of industry-leading litigation technology, has announced that AI SaaS veteran and current Paylocity President and CEO Toby Williams has been appointed to the company's Board of Directors, effective April 22, 2026. "Toby brings a wealth of expertise that is deeply relevant for DISCO as it continues to be at the forefront of litigation technology," said Chairman of the Board Scott Hill. "As a public-company veteran who has worked in AI and cloud-based services across the C-Suite and in the boardroom, Toby has both the hands-on experience and leadership perspective that will be inv

    4/23/26 7:46:00 AM ET
    $LAW
    Computer Software: Prepackaged Software
    Technology

    Magnite Announces Retirement of CFO David Day

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the world's largest independent sell-side advertising platform, today announced the retirement of David Day, Chief Financial Officer (CFO). To ensure a seamless transition, Mr. Day is expected to serve as CFO through September 30, 2026 and then as a special advisor through May 31, 2027. The Board of Directors has initiated a comprehensive search for a new CFO, which will include both external and internal candidates, and Mr. Day will actively participate in the process to find his successor. "David has been an invaluable partner and a steady hand during a period of immense transformation for our company," said Michael Bar

    4/20/26 4:25:00 PM ET
    $MGNI
    Computer Software: Programming Data Processing
    Technology

    Later More Than Doubles Enterprise Business as Influencer Marketing Becomes a Performance Channel

    The company surpasses $2.9B in creator-driven commerce, appoints new CTO and expands AI capabilitiesBOSTON, April 14, 2026 /PRNewswire/ -- Later, the enterprise standard for influencer marketing and social commerce, today announces record performance milestones for Q1 2026. Fueled by strong enterprise momentum and a comprehensive rebrand launched at SXSW 2026, Later reported over 100% year-over-year growth in enterprise business for Q1 2026 as Fortune 500 brands consolidate their creator and social programs around a single, intelligent solution. Later now powers $2.9 billion in

    4/14/26 8:58:00 AM ET
    $RAMP
    EDP Services
    Technology

    $AKA
    $AKU
    $ALRM
    $AMRS
    Financials

    Live finance-specific insights

    View All

    Entravision to Announce First Quarter 2026 Financial Results

    Entravision (NYSE:EVC), a media and advertising technology company, announced today that it will release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. The company will host a webinar to discuss its results followed by a question-and-answer session at 1:30 p.m. PT/ 4:30 p.m. ET the same day. The webinar may be accessed on the company's Investor Relations website at investor.entravision.com or via webinar registration. The webinar will also be archived on the company's Investor Relations website under the Events section. About Entravision Entravision (NYSE:EVC) is a media and advertising technology company. In the U.S., we maintain a diversified

    4/23/26 4:05:00 PM ET
    $EVC
    Broadcasting
    Industrials

    Blend to Announce First Quarter 2026 Financial Results on May 7, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's first quarter 2026 financial results will be released after market close on Thursday, May 7, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs, Inc. (NYSE:BLND) is a leading origination platform for digital banking solutions. Fina

    4/23/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Delcath Systems to Host First Quarter 2026 Earnings Call

    Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 7, 2026, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2026. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call. Event Date: Thursday, May 7, 2026 Time: 8:30 AM Eastern Time Participant Numbers: Toll Free: 1-800-717-1738 International: 1-646-307-1865 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1757946&tp_key=463dd4d428 A replay of the webinar will be available short

    4/23/26 8:30:00 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care